15 related news articles for Inflammatory bowel disease (IBD)

  • A new class of anti-inflammatory could take the STING out of disease

    A naturally occurring molecule found in soy products could hold the clue to a new class of potent anti-inflammatory drugs, targeting diseases ranging from heart conditions to COVID-19.…  Read more

    Associate Professor Michael Gantier's soy-sourced anti-inflammatory research takes the STING out of disease.
  • IBD causing bacteria discovered in mice

    Bacteria that cause weight loss and intestinal inflammation have been identified in the microbiome of mice used to study Inflammatory Bowel Disease (IBD).…  Read more

    Scientist, Dr Sam Forster discovers a bacteria that causes weight loss and intestinal inflammation in the microbiome of mice used to study IBD.
  • Flicking the inflammation off-switch

    Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
    There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.…  Read more

    A/Prof Claudia Nold and Professor Marcel Nold from The Ritchie Centre at Hudson Institute of Medical Research
  • State-of-the art genomic sequencer accelerates inflammation research

    Hudson Institute of Medical Research is progressing its genomic and inflammation research with the acquisition of an Illumina NextSeq 2000, a new sequencing system that provides unprecedented genomic capacity to study inflammatory diseases and microbial diversity.…  Read more

    Dr Sam Forster and Professor Elizabeth Hartland using Illumina NextSeq2000
  • Rachel’s story | Living with Crohn’s disease

    Rachel Botros has suffered from Crohn’s disease since she was a 14-year-old. The chronic condition interrupted her schooling and ability to live a typical teenage life. Her two siblings also have the disease. …  Read more

    Rachel Botros, Crohns disease sufferer
  • Crohn’s disease in Australia – the latest research

    Crohn’s is an inflammatory disease which affects the gastrointestinal tract. It is incurable and usually chronic with periods of flare ups lasting from anywhere from a few days to a several months.…  Read more

    Dr Edward Giles a Senior Research Scientist in the Regulation of Interferon and Innate Signalling group at Hudson Institute
  • NHMRC Ideas Grants success

    Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.…  Read more

    Sam, Paul, Ed and Vince, Hudson Institute's successful NHMRC Ideas Grants recipients
  • Crohn’s disease diagnosis impacts future health

    Crohn’s disease is an incurable inflammatory bowel disease (IBD) affecting more than 60,000 Australians, including children.…  Read more

    Edward Giles from the Regulation of Interferon and Innate Signalling Research Group at Hudson Institute
  • Paving the way towards a new anti-inflammatory agent

    Hudson Institute researchers provide new insights into how the IL-37 protein blocks inflammation—emphasising the potential for a novel treatment in the fight against a plethora of inflammatory diseases.…  Read more

    Dr Ina Rudloff, Postdoctoral Scientist in the Interventional Immunology in Early Life Diseases Research Group at Hudson Institute
  • NHMRC Ideas Grant success

    Hudson Institute has had outstanding success in the NHMRC Ideas Grant round.

    Our researchers have been awarded nine NHMRC Ideas Grants, totalling almost $8.5 million and a success rate of 19.1 per cent.…  Read more

  • More than 100 new gut bacteria discovered in human microbiome

    Scientists working on the gut microbiome have discovered and isolated more than 100 completely new species of bacteria from healthy people’s intestines.…  Read more

    Sam Forster and Gemma D'Adamo and Tam holding up petri dishes conducting research at Hudson Institute
  • NHMRC Fellowship success

    Hudson Institute has had outstanding success in the recent National Health and Medical Research Council (NHMRC) Fellowship and Development Grant announcements.…  Read more

    Associate Professor Rebecca Lim, 2017 NHMRC Grant success
  • Stunning NHMRC Grant success

    Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

    Professor Marcel Nold and A/Professor Claudia Nold from Hudson Institute of Medical Research
  • 2017 L’Oréal-UNESCO for Women in Science Fellowship

    Dr Jaclyn Pearson from the Centre for Innate Immunity and Infectious Diseases has been named as a L’Oréal-UNESCO For Women in Science 2017 Australian Fellow. The prestigious fellowship recognises Dr Pearson’s contribution to science and will support her career progression. Read about what has inspired Dr Pearson and her work.…  Read more

    Dr Jaclyn Pearson from the Host-Pathogen Interactions Research Group at Hudson Institute of Medical Research
  • ‘Bugs as drugs’: Harnessing novel gut bacteria for human health

    Researchers are optimistic that a recent breakthrough allowing growth of the majority of human gut bacteria in the lab will lead to the development of new therapies for human health, replacing the use of faecal transplants in treating certain gut infections.…  Read more

    Dr Sam Forster, 2017 NHMRC Grant success